HYL.BR Forward P/E

The Forward P/E of Hyloris Pharmaceuticals SA (HYL.BR) is N/A.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

HYL.BR Forward P/E - Peers Comparison

Ticker	Name	Value
PHO.OL	Photocure ASA	34.86
PRL.MI	Pierrel SpA	142.57
CLN.WA	Celon Pharma SA	147.06
CLBIO.ST	Corline Biomedical AB	18.44
CALTX.ST	Calliditas Therapeutics AB	89.64
SHE.MI	Shedir Pharma Srl Unipersonale	8.70
OAT.WA	Oncoarendi Therapeutics SA	0.54